2BB score and signals
Telomir Pharmaceuticals, Inc.’s current 2BB score is 23 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 2 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 21 | Weak |
| Quality | 20 | Weak |
| Risk | 42 | Moderate |
Company facts
| Headquarters | Miami, Florida, United States |
| Founded | 2021 |
| Employees | 5 |
| 52-week range | $0.89 – $2.09 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -0.0816 | — | $510,000.00 |
| 2026-08-12 | — | -0.0714 | — | $0.00 |
| 2026-05-13 | — | -0.0714 | — | $0.00 |
| 2026-03-17 | -0.28 | -0.0714 | $0.00 | $0.00 |
Related companies
